Bird & Bird advises InGeneron on divestment of Eticur GmbH
Contacts
Partner
Germany
I am a partner in our Corporate and M&A team in Munich and a member of our Tech & Comms and Life Sciences & Healthcare Sector Groups, offering our clients in-depth experience in all facets of corporate law (transactional and non-transactional), alongside a deep understanding of their sector and business.
Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.
Headquartered in Houston and Munich, InGeneron is a privately held company that was formed to innovate cell-based technologies for healthcare and life sciences research. Eticur has been one of the leading providers of high-quality testing, processing and storage of stem cells from the umbilical cord.
The following Bird & Bird lawyers advised InGeneron: Partner Stefan Münch and Associate Daniel Gloor (both Corporate/M&A, Munich).